Physician profile
Kirth Steele
NPI 1639275548
$5,300.52
in general payments reported to CMS, 2019-2025
30 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 77% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $310 · 2021: $242 · 2022: $752 · 2023: $1,515 · 2024: $523 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,051.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,643.66 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $1,096.27 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.50 | 2019-2024 | Stiolto Respimat, Spiriva Respimat, Ofev |
| E.R. Squibb & Sons, L.L.C. | $280.15 | 2019-2024 | Eliquis |
| Regeneron Healthcare Solutions, INC. | $263.52 | 2019-2025 | Dupixent |
| Sunovion Pharmaceuticals INC. | $250.99 | 2019-2020 | |
| Genzyme Corporation | $209.38 | 2019-2025 | |
| Philips North America LLC | $186.95 | 2019-2023 | |
| Verona Pharma, INC. | $176.77 | 2025 | Ohtuvayre |
| Insmed, INC. | $118.49 | 2019-2025 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $111.14 | 2022-2025 | Opsumit, Uptravi |
| Jazz Pharmaceuticals INC. | $107.89 | 2019-2020 | |
| Amgen INC. | $73.48 | 2025 | Tezspire |
| Mylan Specialty L.P. | $61.76 | 2019-2023 | Yupelri |
| Grifols USA, LLC | $56.71 | 2023-2025 | Prolastin-C Liquid |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $56.58 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.00 | 2022-2023 | Aralast |
| Inogen, INC. | $30.15 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Novartis Pharmaceuticals Corporation | $28.97 | 2019 | |
| Pharming Healthcare, INC. | $28.19 | 2022 | |
| Mallinckrodt Enterprises LLC | $27.91 | 2019 | |
| Covidien Lp | $22.91 | 2019 | |
| Alexion Pharmaceuticals, INC. | $21.77 | 2023 | Ultomiris |
| Phadia US INC. | $20.51 | 2025 | Immunocap |
| Advanced Respiratory, INC | $19.26 | 2019 | |
| Electromed, INC. | $17.01 | 2023 | Smartvest |
| Janssen Pharmaceuticals, INC | $15.00 | 2020 | |
| Shire North American Group INC | $14.77 | 2019 | |
| Sanofi Pasteur INC. | $14.71 | 2019 | |
| Genentech USA, INC. | $12.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirth Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.